(b)(4).Investigation/evaluation: during the course of the investigation, a review of the complaint history, documentation, and instructions for use (ifu) of the product was conducted.No product or medical imaging was provided.The zenith device has completed design control requirements demonstrating that the device meets the predetermined requirements and that the requirements meet the needs of the user.Specifically, design verification testing included water permeability testing, migration resistance testing, and radial force testing.The results met the acceptance criteria.The ifu provides instructions for use, contraindications, warnings and precautions regarding the appropriate method of use.Specifically, it states "additional endovascular interventions or conversion to standard open surgical repair following initial endovascular repair should be considered for patients experiencing an enlarging aneurysm, unacceptable decrease in fixation length (vessel and component overlap) and/or endoleak.An increase in aneurysm size and/or persistent endoleak or migration may lead to aneurysm rupture.Patients experiencing reduced blood flow through the graft limb and/or leaks may be required to undergo secondary interventions or surgical procedures." based on the information provided without the returned complaint device, a definitive root cause could not be determined.Per the quality engineering risk assessment (qera) no further action is required.We will continue to monitor for similar complaints.
|